These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20597032)

  • 21. Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice.
    Tsuda N; Kumadaki S; Higashi C; Ozawa M; Shinozaki M; Kato Y; Hoshida K; Kikuchi S; Nakano Y; Ogawa Y; Furusako S
    PLoS One; 2014; 9(11):e112027. PubMed ID: 25405858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic strategies for metabolic diseases: Small-molecule diacylglycerol acyltransferase (DGAT) inhibitors.
    Naik R; Obiang-Obounou BW; Kim M; Choi Y; Lee HS; Lee K
    ChemMedChem; 2014 Nov; 9(11):2410-24. PubMed ID: 24954424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the key pharmacophore elements of PF-04620110: discovery of a potent, orally-active, neutral DGAT-1 inhibitor.
    Dow RL; Andrews MP; Li JC; Michael Gibbs E; Guzman-Perez A; Laperle JL; Li Q; Mather D; Munchhof MJ; Niosi M; Patel L; Perreault C; Tapley S; Zavadoski WJ
    Bioorg Med Chem; 2013 Sep; 21(17):5081-97. PubMed ID: 23871442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple homogeneous scintillation proximity assay for acyl-coenzyme A:diacylglycerol acyltransferase.
    Seethala R; Peterson T; Dong J; Chu CH; Chen L; Golla R; Ma Z; Panemangalore R; Lawrence RM; Cheng D
    Anal Biochem; 2008 Dec; 383(2):144-50. PubMed ID: 18834848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a single nucleotide polymorphism at intron 16 of the caprine acyl-coenzyme A: diacylglycerol acyltransferase 1 (DGAT1) gene.
    Angiolillo A; Amills M; Urrutia B; Doménech A; Sastre Y; Badaoui B; Jordana J
    J Dairy Res; 2007 Feb; 74(1):47-51. PubMed ID: 16978454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico design of diacylglycerol acyltransferase-1 (DGAT1) inhibitors based on SMILES descriptors using Monte-Carlo method.
    Kumar P; Kumar A; Sindhu J
    SAR QSAR Environ Res; 2019 Aug; 30(8):525-541. PubMed ID: 31331203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor.
    Birch AM; Birtles S; Buckett LK; Kemmitt PD; Smith GJ; Smith TJ; Turnbull AV; Wang SJ
    J Med Chem; 2009 Mar; 52(6):1558-68. PubMed ID: 19256504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.
    Yu T; Wu C; Shih N; Li Q; Chan C; Pan H; Yao D; Pan Y; Liang W; Shen L; Zhao H; Li J; Chen S
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1686-1692. PubMed ID: 29699923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia.
    King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Collins CA; Voorbach MJ; Zhao G; Mittelstadt SW; Cox BF
    Eur J Pharmacol; 2010 Jul; 637(1-3):155-61. PubMed ID: 20385122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.
    Zhou G; Ting PC; Wishart G; Zorn N; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1790-4. PubMed ID: 24618302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of action.
    Liu J; Gorski JN; Gold SJ; Chen D; Chen S; Forrest G; Itoh Y; Marsh DJ; McLaren DG; Shen Z; Sonatore L; Carballo-Jane E; Craw S; Guan X; Karanam B; Sakaki J; Szeto D; Tong X; Xiao J; Yoshimoto R; Yu H; Roddy TP; Balkovec J; Pinto S
    Obesity (Silver Spring); 2013 Jul; 21(7):1406-15. PubMed ID: 23671037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APD-356 (Arena).
    Jandacek RJ
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1051-6. PubMed ID: 16259227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease: emerging mechanisms and consequences.
    Turkish AR
    Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):128-33. PubMed ID: 18301087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC).
    Yu Y; Wu Z; Shi ZC; He S; Lai Z; Cernak TA; Vachal P; Liu M; Liu J; Hong Q; Jian T; Guiadeen D; Krikorian A; Sperbeck DM; Verras A; Sonatore LM; Murphy BA; Wiltsie J; Chung CC; Gorski JN; Liu J; Xiao J; Wolff M; Tong SX; Madeira M; Karanam BV; Shen DM; Balkovec JM; De Vita RJ; Pinto S; Nargund RP
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1380-1385. PubMed ID: 30952592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents.
    Kwak HJ; Pyun YM; Kim JY; Pagire HS; Kim KY; Kim KR; Rhee SD; Jung WH; Song JS; Bae MA; Lee DH; Ahn JH
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4713-8. PubMed ID: 23810496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of triglyceride metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT".
    Turkish A; Sturley SL
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G953-7. PubMed ID: 17095752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
    Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genomics and proteomics of vertebrate diacylglycerol acyltransferase (DGAT), acyl CoA wax alcohol acyltransferase (AWAT) and monoacylglycerol acyltransferase (MGAT).
    Holmes RS
    Comp Biochem Physiol Part D Genomics Proteomics; 2010 Mar; 5(1):45-54. PubMed ID: 20374941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
    King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
    J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.